Hutchmed does healthcare

Hutchmed returns to revenue growth in first half of 2026

Drugmaker Hutchmed (China) Ltd. (HCM.US; 0013.HK) on Thursday reported its revenue rose slightly in the first half of 2026, as double-digit growth for its core portfolio of cancer and immunology…